Can noninvasive evaluation of benign prostatic obstruction be optimized?

Area of Science:

• Urology
• Medical Diagnostics

Background:

• Lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) are increasingly prevalent with longer life expectancy.
• Accurate diagnosis of BPO and differentiation from prostate cancer are critical for effective patient management.

Purpose of the Study:

• To review recent advancements in diagnosing bladder outlet obstruction.
• To explore methods distinguishing benign prostatic obstruction from prostate cancer in patients with LUTS.

Main Methods:

• Review of recently published diagnostic techniques for BPO.
• Analysis of novel ultrasound imaging modalities.
• Evaluation of emerging serum and urine-based biomarkers.

Main Results:

• Ultrasound techniques like prostatic artery resistive index, detrusor wall thickness, and prostatic urethral angle show potential but require further validation.
• Intravesical prostatic protrusion is a promising predictor of obstruction for clinical consideration.
• Novel biomarkers, including prostate-specific antigen and urine prostate cancer gene 3, demonstrate promise for differentiating benign prostatic hyperplasia from prostate cancer.

Conclusions:

• Intravesical prostatic protrusion is a clinically applicable technique for assessing prostatic obstruction.
• Current diagnostic methods do not fully replace urodynamic investigations.
• Future biomarkers hold potential for improved differentiation between benign prostatic hyperplasia and prostate cancer.